However, there was a similar rate of serious drug-related AEs including aphasia, arrhythmia, convulsion, diarrhoea, hepatitis, hypersensitivity, and phosphokinase (CPK) among DTG-based and RAL-based regimens, possibly due to the similar structure of these INIs. The gene discussed is PIK3C2A; the disease is cardiac arrhythmia.